These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10475142)

  • 41. Clindamycin bioavailability and pharmacokinetics following oral administration of clindamycin hydrochloride capsules in dogs.
    Batzias GC; Delis GA; Athanasiou LV
    Vet J; 2005 Nov; 170(3):339-45. PubMed ID: 16266847
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bioavailability of two oral formulations of loratadine 20 mg with concomitant ketoconazole: an open-label, randomized, two-period crossover comparison in healthy Mexican adult volunteers.
    Piñeyro-López A; Pineyro-Garza E; Torres-Alanís O; Reyes-Araiza R; Gómez Silva M; Wacksman N; Lujàn Rangel R; de Lago A; Trejo D; Gonzàlez-de la Parra M; Namur S
    Clin Ther; 2006 Jan; 28(1):110-5. PubMed ID: 16490584
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Biochemical studies with oxitropium bromide. 2. Pharmacokinetics and metabolism in humans].
    Wahl D; van Wayjen RG; van den Ende AA
    Arzneimittelforschung; 1985; 35(1A):266-72. PubMed ID: 4039167
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A study relating to bioavailability and renal elimination of bismuth after oral administration of basic bismuth nitrate.
    Behrendt WA; Gröger C; Kuhn D; Schulz HU; Topfmeier P
    Int J Clin Pharmacol Ther Toxicol; 1991 Sep; 29(9):357-60. PubMed ID: 1937997
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Influence of age on the pharmacokinetics of ciprofloxacin.
    Nilsson-Ehle I; Ljungberg B
    Scand J Infect Dis Suppl; 1989; 60():23-7. PubMed ID: 2756350
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetics of 14C-isotretinoin in healthy volunteers and volunteers with biliary T-tube drainage.
    Colburn WA; Vane FM; Bugge CJ; Carter DE; Bressler R; Ehmann CW
    Drug Metab Dispos; 1985; 13(3):327-32. PubMed ID: 2861992
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Patients confined in bed for an extended period and developing cholinergic crisis following administration of distigmine bromide: report of 3 cases].
    Tadara R; Kobayashi M; Nakamura N; Suzuki Y; Isono S
    Nihon Naika Gakkai Zasshi; 1998 Aug; 87(8):1566-7. PubMed ID: 9780688
    [No Abstract]   [Full Text] [Related]  

  • 48. Bioavailability and pharmacokinetics of D-penicillamine.
    Kukovetz WR; Beubler E; Kreuzig F; Moritz AJ; Nirnberger G; Werner-Breitenecker L
    J Rheumatol; 1983 Feb; 10(1):90-4. PubMed ID: 6842492
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Fosfomycin-trometamol (monuril): pharmacokinetics and food-drug interactions].
    Muller-Serieys C; Bergogne-Berezin E; Joly-Guillou ML
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):753-6. PubMed ID: 3309810
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetics and metabolism of antipyrine (phenazone) after intravenous and oral administration.
    Eichelbaum M; Ochs HR; Roberts G; Somogyi A
    Arzneimittelforschung; 1982; 32(5):575-8. PubMed ID: 7201837
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [A case of acute distigmine bromide intoxication in the therapeutic dosage for treatment of underactive neurogenic bladder].
    Tada M; Fujita N; Umeda M; Koike H; Nagai H
    No To Shinkei; 2004 May; 56(5):415-9. PubMed ID: 15279199
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Human pharmacokinetics and metabolism of 14C-labeled gliquidone (AR-DF 26)].
    Kopitar Z
    Arzneimittelforschung; 1975 Sep; 25(9):1455-60. PubMed ID: 1103897
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Renal elimination of magnesium as a parameter of bioavailability of oral magnesium therapy.
    Kuhn I; Jost V; Wieckhorst G; Theiss U; Lücker PW
    Methods Find Exp Clin Pharmacol; 1992 May; 14(4):269-72. PubMed ID: 1507928
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cholinergic crisis following treatment of postoperative urinary retention with distigmine bromide.
    Hameed A; Charles TJ
    Br J Clin Pract; 1994; 48(2):103-4. PubMed ID: 7912951
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Bioavailability of theophylline after oral administration of a retard preparation of theophylline-ethylenediamine and the influence of 15-day ingestion on elimination kinetics after i.v. injection (author's transl)].
    Wiessmann KJ
    Arzneimittelforschung; 1980; 30(2):329-32. PubMed ID: 7378114
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacokinetics of ambenonium, a reversible cholinesterase inhibitor, in rats.
    Yamamoto K; Kohda Y; Sawada Y; Iga T
    Biopharm Drug Dispos; 1991 Nov; 12(8):613-25. PubMed ID: 1801966
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A further report on the effect of distigmine bromide (Ubretid) on the neurogenic bladder.
    Yeo J; Southwell P; Rutowski S; Marchant-Williams H
    Med J Aust; 1974 Aug; 2(6):201-3. PubMed ID: 4424051
    [No Abstract]   [Full Text] [Related]  

  • 58. Effect of Patient Age, Dose, and Chronic Kidney Disease on the Risk of Adverse Reactions to Distigmine.
    Mitsuboshi S; Nagai K; Okajima H
    Biol Pharm Bull; 2020; 43(8):1275-1278. PubMed ID: 32741950
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacokinetics of the 5-hydroxytryptamine1A agonist 8-hydroxy-2-(N,N-di-n-propylamino)tetralin (8-OHDPAT) in the rat after intravenous and oral administration.
    Mason JP; Dring LG; Caldwell J
    Xenobiotica; 1995 Dec; 25(12):1371-80. PubMed ID: 8719911
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oral kinetics and bioavailability of the cholinesterase reactivator HI-6 after administration of 2 different formulations of tablets to dogs.
    Maksimović M; Jovanović D; Kovacević V; Bokonjić D
    Toxicol Lett; 1987 Nov; 39(1):85-91. PubMed ID: 3672559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.